Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,041.7
-

 

  • STI Straits Times Index
    3,041.7
    -
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,527.9
    -20.6 (-1.33%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,099.1
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,076.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,423.4M
  • Value: 1,459.4M
  • Rise: 78
  • Fall: 304
  • Unch: 373

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.065-0.008
Sembcorp Marine0.082-0.002
Medi Lifestyle0.033-0.001
Singtel2.440+0.010
CapLand IntCom T2.000-
YZJ Shipbldg SGD1.440-0.040
Intl Cement0.031-0.002
Jiutian Chemical0.077-0.005
VCPlus0.027+0.001
CapitaLandInvest2.950-

World Indices

World Indices
Name Last Change
Nasdaq 14,713.9 -330.1
HSI 24,099.1
HSCEI 8,638.5
Jakarta 6,076.3
Nikkei 225 30,500.0
SSE Comp 3,614.0
Shanghai A 3,787.7
Shanghai B 273.1
KOSPI 3,130.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

VECTIVBIO HLDG AG VECTIVBIO HOLDING AG
Updated on 17 Sep 2021 (End of trading day)
Last (USD): 7.650 Change: -0.250 High: 8.000 Remarks: -
Change (%): -3.16 Low: 7.625
Open 7.750 Yesterday's Close 7.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,744 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.76227 Trailing EPS (USD) e -1.76227 NAV (USD) b 0.9478
PE a - Trailing PE f - Price / NAV b 8.0713
Dividend (USD) d - Cash In Hand (USD) g 1.1810 Issued & Paid-up Shares c 34,014,600
Dividend Yield (%) d - Price / Cash In Hand g 6.478 Treasury Shares h 722,275
Market Cap (M) 260.212 Enterprise Value (M) 220.156
Piotroski F Score 2 Exchange Code VECT Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 37.3
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 12 Apr 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 Apr 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference VECTIVBIO HLDG AG NASDAQ 260.212 - - 8.0713 -
Industry Pharmaceuticals: Major NASDAQ 2,339.902 86.910 91.614 3.3409 1.403
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 172,139.326 53.861 45.648 10.9811 2.089
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 122,252.873 8.709 17.654 1.6302 2.764
Local Peer ROYALTY PHARMA PLC NASDAQ 23,376.122 23.975 24.061 4.0770 0.498
Local Peer REPLIGEN CORP NASDAQ 16,872.503 281.554 168.838 10.5251 -
Local Peer VIATRIS INC NASDAQ 16,410.065 - - 0.7738 -
Local Peer CUREVAC NV NASDAQ 10,262.584 - - - -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 9,169.892 - - 11.2474 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 6,729.946 - - 6.8339 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,342.815 - - 18.6606 -
Local Peer ALLAKOS INC NASDAQ 5,895.338 - - 10.3248 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,837.613 85.562 85.562 6.7844 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,442.766 - - 18.5202 -
Other Local Peers GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ERASCA INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), GENERATION BIO CO (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KRONOS BIO INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), ICOSAVAX INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), GH RESEARCH PLC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), BEYONDSPRING INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), PHARVARIS NV (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), AC IMMUNE SA (NASDAQ), CLENE INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), PROVENTION BIO INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), ESSA PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NEXIMMUNE INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), XOMA CORP (NASDAQ), OBSEVA SA (NASDAQ), INOZYME PHARMA INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), MUSTANG BIO INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), HARROW HEALTH INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), IMMUNIC INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), ALZAMEND NEURO INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), TRICIDA INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NOVAN INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), GENPREX INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EYENOVIA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), GRAYBUG VISION INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), RENOVORX INC (NASDAQ), MANNATECH INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), SEQLL INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 433,701.080 29.475 24.410 6.2331 2.416
Global Peer PFIZER INC NYSE 246,077.624 25.590 18.603 3.5133 3.461
Global Peer ELI LILLY AND COMPANY NYSE 220,109.288 35.538 36.258 34.1552 1.286
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 203,225.382 25.027 22.595 3.7605 2.309
Global Peer ABBVIE INC NYSE 190,378.301 41.786 28.893 15.1466 4.488
Global Peer MERCK & CO INC NYSE 181,448.602 25.675 32.570 5.4499 3.458
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 179,755.310 27.896 25.250 17.1931 1.327
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 136,237.564 - - 3.7013 3.031
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 97,942.819 13.285 16.513 4.6107 5.315
Global Peer WUXI APPTEC HKEx 534,219.675 160.960 115.360 12.1010 0.195
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), SINOPHARM (HKEx), HUTCHMED (HKEx), REMEGEN-B (HKEx), SH PHARMA (HKEx), JUNSHI BIO (HKEx), HYGEIA HEALTH (HKEx), CMS (HKEx), AKESO-B (HKEx), BAIYUNSHAN PH (HKEx), INNOCARE-B (HKEx), CARSGEN-B (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), SIMCERE PHARMA (HKEx), EVEREST MED-B (HKEx), TRAD CHI MED (HKEx), ADC THERAPEUTICS SA (NYSE), CSTONE PHARMA-B (HKEx), HENLIUS (HKEx), SSY GROUP (HKEx), ZYMEWORKS INC (NYSE), OCUMENSION-B (HKEx), HEPALINK (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), UNITED LAB (HKEx), IMMUNOTECH-B (HKEx), TONGRENTANGCM (HKEx), SCICLONE PHARMA (HKEx), ANTENGENE-B (HKEx), Kimia Farma Tbk. (IDX), CKLIFE SCIENCES (HKEx), SHINEWAY PHARM (HKEx), HUA MEDICINE-B (HKEx), ZHAOKE OPHTH-B (HKEx), Soho Global Health Tbk. (IDX), STARPHARMA HOLDINGS LIMITED (ASX), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), CYBIN INC (NYSE American), TOT BIOPHARM-B (HKEx), AFT PHARMACEUTICALS LTD (ASX), DAWNRAYS PHARMA (HKEx), BSTEAD (Bursa), ANNOVIS BIO INC (NYSE American), PHARMA (Bursa), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARM (HKEx), IP (SET), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), LANNETT CO INC (NYSE), IX Biopharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), CRESO PHARMA LTD (ASX), CHARMACY PHAR (HKEx), KOTRA (Bursa), NEW RAY MEDIC (HKEx), SANAI HEALTH GP (HKEx), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), NOVA (Bursa), Hyphens Pharma (SGX), INVION LTD (ASX), BIOHLDG (Bursa), MODERN CHI MED (HKEx), EXOPHARM LTD (ASX), NEP INTERLONG (HKEx), PHARMAXIS (ASX), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), PURAPHARM (HKEx), AGEX THERAPEUTICS INC (NYSE American), TIMBER PHARMACEUTICALS INC (NYSE American), PALLA PHARMA LTD (ASX), EXTRAWELL PHAR (HKEx), JCT (SET), SUNZEN (Bursa), ONCOSIL MEDICAL LIMITED (ASX), ACRUX (ASX), IMMURON LIMITED (ASX), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), SUDA PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.060
+0.79 %
10 Days --0.660
-7.94 %
20 Days -+0.460
+6.40 %
Medium Term Return 3 Months --6.850
-47.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.690 - 37.700 Change From 1 Year Low +0.960 % Change From 1 Year Low (%) +14.35
Change From 1 Year High -30.050 % Change From 1 Year High (%) -79.71
2 Years Range 6.690 - 37.700 Change From 2 Years Low +0.960 % Change From 2 Years Low (%) +14.35
Change From 2 Years High -30.050 % Change From 2 Years High (%) -79.71
5 Years Range 6.690 - 37.700 Change From 5 Years Low +0.960 % Change From 5 Years Low (%) +14.35
Change From 5 Years High -30.050 % Change From 5 Years High (%) -79.71
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

VectivBio Holding AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for pati